(VIANEWS) – J.MARTINS,SGPS (JMT.LS), MEDISTIM (MEDI.OL), NEURONES (NRO.PA) are the highest payout ratio stocks on this list.
We have collected information about stocks with the highest payout ratio up to now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. J.MARTINS,SGPS (JMT.LS)
88.48% Payout Ratio
Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal. In addition, it operates restaurants under the Pingo Doce name; Bem-Estar pharmacies; petrol stations; and clothing under Code brand. Further, the company operates kiosks and coffee shops under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; the purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; and provision of economic and accounting, business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. is a subsidiary of Sociedade Francisco Manuel dos Santos, SGPS, S.E.
Earnings Per Share
As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €0.52.
PE Ratio
J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 40.84. Meaning, the purchaser of the share is investing €40.84 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.27%.
Yearly Top and Bottom Value
J.MARTINS,SGPS’s stock is valued at €21.28 at 22:10 EST, below its 52-week high of €23.30 and way above its 52-week low of €17.67.
More news about J.MARTINS,SGPS.
2. MEDISTIM (MEDI.OL)
70.22% Payout Ratio
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.23.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 44.46. Meaning, the purchaser of the share is investing kr44.46 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.83%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.6%, now sitting on 491.94M for the twelve trailing months.
More news about MEDISTIM.
3. NEURONES (NRO.PA)
58.48% Payout Ratio
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, clouds, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP integration and outsourcing; mobility, data, IoT, digital, agile, UX/UI, and DevOps; IT consulting for finance, big data, AI and blockchain; content management, business process management, paperless process; and IT training and working with change management. In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is headquartered in Nanterre, France.
Earnings Per Share
As for profitability, NEURONES has a trailing twelve months EPS of €1.27.
PE Ratio
NEURONES has a trailing twelve months price to earnings ratio of 30.47. Meaning, the purchaser of the share is investing €30.47 for every euro of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.4%, now sitting on 665.4M for the twelve trailing months.
Volume
Today’s last reported volume for NEURONES is 2196 which is 38.6% below its average volume of 3577.
Moving Average
NEURONES’s value is below its 50-day moving average of €40.15 and above its 200-day moving average of €37.12.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 8, 2022, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 2.65%.
More news about NEURONES.
4. PERNOD RICARD (RI.PA)
44.21% Payout Ratio
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. The company was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.33.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 22.22. Meaning, the purchaser of the share is investing €22.22 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.84%.
Volume
Today’s last reported volume for PERNOD RICARD is 159326 which is 66.61% below its average volume of 477195.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 25, 2022, the estimated forward annual dividend rate is 4.12 and the estimated forward annual dividend yield is 1.97%.
Sales Growth
PERNOD RICARD’s sales growth is 7.9% for the ongoing quarter and 7.9% for the next.
Moving Average
PERNOD RICARD’s value is higher than its 50-day moving average of €196.78 and way above its 200-day moving average of €188.24.
More news about PERNOD RICARD.
5. REMY COINTREAU (RCO.PA)
31.73% Payout Ratio
Rémy Cointreau SA, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. The company operates through Rémy Martin, Liqueurs & Spirits, and Partner Brands segments. It offers liqueurs, brandy, gin, single malt whisky, rum, wine, and champagne primarily under the Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, Port Charlotte, Octomore, The Botanist, Westland, LOUIS XIII, and Domaine des Hautes Glaces brands. The company operates in Europe, the Middle East, Africa, the Americas, Asia, Australia, and New Zealand. Rémy Cointreau SA was founded in 1724 and is headquartered in Cognac, France.
Earnings Per Share
As for profitability, REMY COINTREAU has a trailing twelve months EPS of €1.67.
PE Ratio
REMY COINTREAU has a trailing twelve months price to earnings ratio of 98.15. Meaning, the purchaser of the share is investing €98.15 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.16%.
Yearly Top and Bottom Value
REMY COINTREAU’s stock is valued at €164.10 at 22:10 EST, way below its 52-week high of €198.60 and higher than its 52-week low of €151.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 1.53B for the twelve trailing months.
More news about REMY COINTREAU.
